Neuronavigated Repetitive Transcranial Magnetic Stimulation (nrTMS) of the Dorsolateral Prefrontal and Primary Motor Cortex for the Treatment of Chronic Pain
1 other identifier
interventional
34
1 country
1
Brief Summary
This study investigated the effects of navigated repetitive Transcranial Magnetic Stimulation on nociception and quality of life in patients suffering from chronic pain conditions. Two cortical targets (dorsolateral prefrontal cortex/DLPFC and M1 area) were stimulated and compared to Sham stimulation.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable chronic-pain
Started Feb 2019
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
February 1, 2019
CompletedPrimary Completion
Last participant's last visit for primary outcome
March 31, 2020
CompletedStudy Completion
Last participant's last visit for all outcomes
October 30, 2020
CompletedFirst Submitted
Initial submission to the registry
June 14, 2021
CompletedFirst Posted
Study publicly available on registry
June 22, 2021
CompletedJuly 1, 2021
June 1, 2021
1.2 years
June 14, 2021
June 28, 2021
Conditions
Outcome Measures
Primary Outcomes (1)
Numeric Rating Scale
0-10 0 = no pain, 10 = worst pain
36 weeks
Secondary Outcomes (1)
Self-reported "Depression, Anxiety and Stress Scale" (DASS) questionnaire.
36 weeks
Study Arms (3)
M1 stimulation
ACTIVE COMPARATOR10 Hz stimulation of left motor area
DLPFC stimulation
ACTIVE COMPARATOR5 Hz stimulation of left dorsolateral prefrontal cortex
Sham TMS
SHAM COMPARATORSham TMS over the left M1 area
Interventions
High frequency nrTMS over 13 sessions (1800-2000 pulses per session) over DLPFC and M1 cortical areas.
Eligibility Criteria
You may qualify if:
- age between 18 and 80 years
- clinical diagnosis of chronic LBP (low back pain) and or neck pain
- average resting pain-level \> than 3 in the Numeric Rating Scale (0-10)
- no changes in pain medication 4 weeks at baseline
- no surgical procedures in the last 2 years
You may not qualify if:
- metallic and electronic implants in the head, neck and chest
- medication e.g. tetracyclic antidepressants, antiviral, antipsychotic, opioid doses \> 100mg orally/d
- history of frequent headache or tinnitus
- alcohol or drug abuse
- pregnant patients
- breastfeeding patients
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Medical University Graz
Graz, Styria, 8010, Austria
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- PARTICIPANT
- Masking Details
- Sham stimulation was provided by turning the TMS coil to the non-stimulating side.
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
June 14, 2021
First Posted
June 22, 2021
Study Start
February 1, 2019
Primary Completion
March 31, 2020
Study Completion
October 30, 2020
Last Updated
July 1, 2021
Record last verified: 2021-06
Data Sharing
- IPD Sharing
- Will not share